Delivery Order 36F79721D0141-36C24523N0643
Award Date 6/12/23
Potential Completion Date 6/16/23
Potential Value $65K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Recordati Rare Diseases, Inc. was awarded a $40,491.84 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of 40 mg doses of pasireotide to the Bartlett, Tennessee location, with performance required by March 9th, 2022. The contract utilizes Master Schedule contract FSS-61-IB but did not include any set aside...
- Recordati Rare Diseases, Inc. was awarded a $50,558.05 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract to provide 20 mg doses of pasireotide for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The delivery order, issued on September 1, 2022, has a completion date of September 2, 2022 and will deliver the requested pharmaceutical products to a location in Bartlett,...
- Recordati Rare Diseases, Inc. was awarded a $20,223 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of 40 mg doses of pasireotide to the Bartlett, Tennessee facility, with work to be completed by July 6, 2022. The parent GSA Schedule provides pharmaceutical products and drugs to federal agencies and no set-aside...
- Recordati Rare Diseases, Inc. was awarded a $9,676.46 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of 40 mg doses of pasireotide to the Bartlett, Tennessee facility, with completion required by December 6, 2021. The contract utilizes Master Schedule contract FSS-61-IB and does not contain any set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $62,000 delivery order to Recordati Rare Diseases, Inc. for pasireotide in various dosages under the firm fixed price Pharmaceuticals and Drugs Federal Supply Schedule contract. The order is for the supply of pasireotide 40 mg, 0.6 mg, and 0.9 mg products, with performance at a location in Bartlett, Tennessee. No set-aside provisions were applied to this award made to Recordati...
- Recordati Rare Diseases, Inc. was awarded a $21,756.52 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The delivery order, which has no set-aside designation, calls for the delivery of 40 mg doses of pasireotide to Bartlett, Tennessee by its May 16, 2023 completion date. Pasireotide is used to treat Cushing's disease and acromegaly,...
- Recordati Rare Diseases, Inc. was awarded a $20,223.22 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to provide PASIREOTIDE 20MG KITs to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for delivery to a location in Bartlett, Tennessee, with performance required by May 4, 2022. No set-aside provisions were applied to this order placed under the vendor's master schedule...
- Recordati Rare Diseases, Inc. was awarded a $19,352.92 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of 40 mg doses of pasireotide to Bartlett, Tennessee, with performance required by October 22, 2021. The parent Federal Supply Schedule was established under GSA Schedule 61-IB and provides pharmaceutical products...
- Recordati Rare Diseases Inc. was awarded a $22,438.42 firm fixed-price delivery order by Veterans Integrated Service Network 5 (VISN 5) for SIGNIFOR LAR 40 MG, a specialized pharmaceutical treatment for rare endocrine disorders such as Cushing's disease and acromegaly. The delivery order, awarded on December 5, 2025, with an ultimate completion date of December 9, 2025, will be performed in Bartlett, Tennessee. This award carries no set-aside designation and falls under the Pharmaceuticals and...
- Recordati Rare Diseases Inc. was awarded a delivery order against its Pharmaceuticals and Drugs Federal Supply Schedule contract to provide Signifor LAR 30 mg and 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The potential value of this firm fixed price order is $21,623.35 to be performed at a place of performance in Bartlett, Tennessee by January 31, 2024. Recordati holds two key indefinite-delivery vehicles for supplying...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79721D0141Federal Supply Schedule
- 36F79721D0141-36C24523N0643Delivery Order
Recordati Rare Diseases, Inc. was awarded a $65,239.74 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract to provide pasireotide 20 mg and 40 mg to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order has a period of performance through June 16, 2023 for the Bartlett, Tennessee place of performance. No set-aside provisions were applied to this order to supply the specified pharmaceutical products in support of healthcare services for veterans within the Network 5 region.
Generated 1/2/24, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($30) | 6/13/23 | |
| Not listed | Not listed | $65.3k | 6/12/23 |